Coming December: ASH publishes its late-breaking abstracts. We’ll add the organizations presenting them.

Veloxis Pharmaceuticals at ASH 2026

Dec 12–15, 2026 New Orleans, LA ~30k attendees Website

Veloxis Pharmaceuticals at ASH 2026 in New Orleans.

OrganizationASH 2026 Attendance
Biotech
Specialty pharmaceutical company owned by Asahi Kasei, developing and selling medicines for transplant patients and related serious diseases.
No longer listed on the exhibitor list or the program under this name: Veloxis Pharmaceuticals is now part of Asahi Kasei Therapeutics (Booth 2547)

Explore the full ASH 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in New Orleans. Leave your work email and we’ll be in touch.

Privacy

Download the full ASH 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Veloxis Pharmaceuticals

Tell us what you sell and we’ll find the people at Veloxis Pharmaceuticals most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction